NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Endo International plc (NASDAQ: ENDP)

ENDP Technical Analysis
As on 1st Jul 2022 ENDP Share Price closed @ 0.57 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.53 & Strong Sell for SHORT-TERM with Stoploss of 8.16 we also expect STOCK to react on Following IMPORTANT LEVELS.

ENDP Share Price

Open 0.40 Change Price %
High 0.62 1 Day 0.10 21.28
Low 0.37 1 Week 0.21 58.33
Close 0.57 1 Month -0.05 -8.06
Volume 199580740 1 Year -6.55 -91.99
52 Week High 10.55 | 52 Week Low 0.30
NASDAQ USA Most Active Stocks
ENDP 0.57 21.28%
ALNA 0.21 10.53%
XELA 0.11 0.00%
AMD 73.67 -3.66%
CLVS 2.85 58.33%
AKBA 0.39 11.43%
AMZN 109.56 3.15%
AAPL 138.93 1.62%
NVDA 145.23 -4.20%
AGRX 0.64 -45.30%
NASDAQ USA Top Gainers Stocks
REDU 3.41 1075.86%
NDRAW 0.03 200.00%
RCRTW 0.29 141.67%
RMGCW 0.18 125.00%
LCAAW 0.20 100.00%
ENJYW 0.02 100.00%
PTIXW 0.15 87.50%
FRSGW 0.18 80.00%
SPTKW 0.07 75.00%
OMER 4.64 68.73%
NASDAQ USA Top Losers Stocks
GGGVR 0.00 -100.00%
PTRAW 0.23 -89.59%
DTOCW 0.07 -74.07%
ITQRW 0.03 -62.50%
MPACW 0.04 -60.00%
NLITW 0.11 -52.17%
NAACW 0.06 -50.00%
MBTCR 0.02 -50.00%
BTAQW 0.01 -50.00%
ALACW 0.01 -50.00%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
ENDP Important Levels Intraday
ENDP Target for Month July
4th UP TARGET8.76
3rd UP TARGET6.13
2nd UP TARGET4.51
1st UP TARGET2.89
1st DOWN TARGET-1.75
2nd DOWN TARGET-3.37
3rd DOWN TARGET-4.99
4th DOWN TARGET-7.62
ENDP Weekly Target
4th UP TARGET2.00
3rd UP TARGET1.54
2nd UP TARGET1.26
1st UP TARGET0.97
2nd DOWN TARGET-0.12
3rd DOWN TARGET-0.40
4th DOWN TARGET-0.86
ENDP Target for Year 2022
4th UP TARGET21.02
3rd UP TARGET14.46
2nd UP TARGET10.41
1st UP TARGET6.35
1st DOWN TARGET-5.21
2nd DOWN TARGET-9.27
3rd DOWN TARGET-13.32
4th DOWN TARGET-19.88
ENDP Other Details
Segment EQ
Market Capital 987705024.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
ENDP Address
ENDP Latest News
Your Comments and Response on Endo International plc
ENDP Business Profile
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. Address: Minerva House, Dublin, Ireland, 4
2005-2021 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service